- About About
-
Medical
Medical
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
-
-
House Vote Would Continue Prohibition on Federal Interference in State-Level Medical Marijuana Programs in 39 States
Washington, DC- The United States House of Representatives voted to reauthorize the Rohrabacher-Farr medical cannabis (marijuana) amendment to the Commerce, Science, and Justice (CJS) Appropriations bill for fiscal year 2015 by a margin of 242 to 186. The Rohrabacher-Farr medical cannabis amendment bans the Department of Justice from spending money to prevent the implementation of state-level medical cannabis programs, removing funding for federal medical cannabis raids, arrests and prosecutions in states where medical cannabis is legal. With the addition of seven states in the last year the Rohrabacher-Farr medical cannabis amendment now covers 39 states and protects access to medical cannabis programs for 275 million citizens in those states.
“The Rohrabacher-Farr medical cannabis amendment offers crucial protection for medical cannabis patients and the people that provide them with access to much needed medicine,” said Steph Sherer Americans for Safe Access Executive Director. “Having reaffirmed the federal government’s commitment to not interfere with state medical cannabis programs it’s now time to move forward and create a framework for federal and state cooperation in medical cannabis by passing the CARERS Act."
Last year the House of Representatives passed the Rohrabacher-Farr medical cannabis amendment by a margin of 219-189 with a strong bipartisan show of support. Lead by the support of Senator Barbara Mikulski (D-MD) the Rohrabacher-Farr medical cannabis amendment remained in the CRomnibus bill that President Obama signed into law. Its passage marked the first time Congress approved a medical cannabis reform since designating cannabis in Schedule I of the Controlled Substances Act. Today approximately 2.4 million Americans currently utilize medical cannabis programs.
“With the recent addition of Texas the vast majority of the country is now living in a state with at least some legal use of medical cannabis,” said Mike Liszewski Americans for Safe Access Government Affairs Director. “This vote shows the growing recognition that the only responsible course of action is for the federal government to leave state medical cannabis programs alone and let them provide their citizens with this much needed medical option.”
The Rohrabacher-Farr medical cannabis amendment was co-sponsored by a bipartisan coalition of six Republicans and six Democratic members including Dana Rohrabacher (R-CA), Sam Farr (D-CA), Reid Ribble (R-WI), Barbara Lee (D-CA), Thomas Massie (R-KY), Earl Blumenauer (D-OR), Joe Heck (R-NV), Steve Cohen (D-TN), Don Young (R-AK) Jared Polis (D-CO), Tom McClintock (R-CA), Dina Titus (D-NV).
Further Information:
Share